<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27484768</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6882</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><PubDate><Year>2016</Year><Month>Aug</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC complementary and alternative medicine</Title><ISOAbbreviation>BMC Complement Altern Med</ISOAbbreviation></Journal><ArticleTitle>Inhibitory effects of an aqueous extract from Cortex Phellodendri on the growth and replication of broad-spectrum of viruses in vitro and in vivo.</ArticleTitle><Pagination><StartPage>265</StartPage><MedlinePgn>265</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">265</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12906-016-1206-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cortex Phellodendri (C. Phellodendri), the dried trunk bark of Phellodendron amurense Ruprecht, has been known as a traditional herbal medicine, showing several bioactivities. However, antiviral activity of C. Phellodendri aqueous extract (CP) not reported in detail, particularly aiming the prophylactic effectiveness.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In vitro CP antiviral activity evaluated against Influenza A virus (PR8), Vesicular Stomatitis Virus (VSV), Newcastle Disease Virus (NDV), Herpes Simplex Virus (HSV), Coxsackie Virus (H3-GFP) and Enterovirus-71 (EV-71) infection on immune (RAW264.7) and epithelial (HEK293T/HeLa) cells. Such antiviral effects were explained by the induction of antiviral state which was determined by phosphorylation of signal molecules, secretion of IFNs and cytokines, and cellular antiviral mRNA expression. Furthermore, Compounds present in the aqueous fractions confirmed by HPLC analysis and evaluated their anti-viral activities. Additionally, in vivo protective effect of CP against divergent influenza A subtypes was determined in a BALB/c mouse infection model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">An effective dose of CP significantly reduced the virus replication both in immune and epithelial cells. Mechanically, CP induced mRNA expression of anti-viral genes and cytokine secretion in both RAW264.7 and HEK293T cells. Furthermore, the main compound identified was berberine, and shows promising antiviral properties similar to CP. Finally, BALB/c mice treated with CP displayed higher protection levels against lethal doses of highly pathogenic influenza A subtypes (H1N1, H5N2, H7N3 and H9N2).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">CP including berberine play an immunomodulatory role with broad spectrum antiviral activity, due to induction of antiviral state via type I IFN stimulation mechanism. Consequently, C. Phellodendri could be a potential source for promising natural antivirals or to design other antiviral agents for animal and humans.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae-Hoon</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weeratunga</LastName><ForeName>Prasanna</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Myun Soo</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Vitabio, Inc., Daejeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikapitiya</LastName><ForeName>Chamilani</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Byeong-Hoon</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Md Bashir</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sylhet Agricultural University, Sylhet, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae-Hwan</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Ji-Eun</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Chung</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>LINC Project Group, Daejeon University, 62 Daehak-Ro, Dong-Gu, Daejeon, 300-716, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jin Yeul</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Korean Medicine (KM) Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, Deajeon, 305-764, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hongik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Vitabio, Inc., Daejeon, 305-764, Republic of Korea. hongiknice@hanmail.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong-Soo</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon, 305-764, Republic of Korea. jongsool@cnu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Complement Altern Med</MedlineTA><NlmUniqueID>101088661</NlmUniqueID><ISSNLinking>1472-6882</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032102" MajorTopicYN="N">Phellodendron</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024301" MajorTopicYN="N">Plant Bark</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067996" MajorTopicYN="N">RAW 264.7 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-viral effect</Keyword><Keyword MajorTopicYN="N">Berberine</Keyword><Keyword MajorTopicYN="N">Cortex Phellodendri</Keyword><Keyword MajorTopicYN="N">Herbal medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27484768</ArticleId><ArticleId IdType="pmc">PMC4970287</ArticleId><ArticleId IdType="doi">10.1186/s12906-016-1206-x</ArticleId><ArticleId IdType="pii">10.1186/s12906-016-1206-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lemon SM, Mahmoud AA. The threat of pandemic influenza: are we ready? Biosecurity and bioterrorism : biodefense strategy, practice, and science. 2005;3:70&#x2013;73. doi: 10.1089/bsp.2005.3.70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bsp.2005.3.70</ArticleId><ArticleId IdType="pubmed">15853457</ArticleId></ArticleIdList></Reference><Reference><Citation>Arzt J, White WR, Thomsen BV, Brown CC. Agricultural diseases on the move early in the third millennium. Vet. Pathol. 2010;47:15&#x2013;27. doi: 10.1177/0300985809354350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300985809354350</ArticleId><ArticleId IdType="pubmed">20080480</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, Parveen Z. Antiviral potentials of medicinal plants. Virus Res. 2008;131:111&#x2013;120. doi: 10.1016/j.virusres.2007.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2007.09.008</ArticleId><ArticleId IdType="pmc">PMC7114233</ArticleId><ArticleId IdType="pubmed">17981353</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian YF, Mao QQ, Ip SP, Lin ZX. Che CT Comparison on the anti-inflammatory effect of Cortex Phellodendri Chinensis and Cortex Phellodendri Amurensis in 12-O-tetradecanoyl-phorbol-13-acetate-induced ear edema in mice. J. Ethnopharm. 2011;137:1425&#x2013;1430. doi: 10.1016/j.jep.2011.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2011.08.014</ArticleId><ArticleId IdType="pubmed">21875660</ArticleId></ArticleIdList></Reference><Reference><Citation>Magadula S. Cytotoxic and anti-HIV activities of some Tanzanian Garcinia species. Tanzania J Health Res. 2010;12(2):1&#x2013;7. doi: 10.4314/thrb.v12i2.56402.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/thrb.v12i2.56402</ArticleId></ArticleIdList></Reference><Reference><Citation>Strober W. Trypan blue exclusion test of cell viability. Current protocols in immunology. 2001;Appendix 3:Appendix 3B.</Citation><ArticleIdList><ArticleId IdType="pubmed">18432654</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon HJ, Lee JS, Choi YK, Park JY, Talactac MR, Chowdhury MY, Poo H, Sung MH, Lee JH, Jung JU, et al. Induction of type I interferon by high-molecular poly-gamma-glutamate protects B6.A2G-Mx1 mice against influenza A virus. Antiviral Res. 2012;94:98&#x2013;102. doi: 10.1016/j.antiviral.2012.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.02.010</ArticleId><ArticleId IdType="pubmed">22401806</ArticleId></ArticleIdList></Reference><Reference><Citation>Seal BS, King DJ, Bennett JD. Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis. J. clin. microb. 1995;33(10):2624&#x2013;2630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC228544</ArticleId><ArticleId IdType="pubmed">8567895</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed JR, Leon RP, Hall MK, Schwertfeger KL. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. BCR. 2009;11(2):R21. doi: 10.1186/bcr2246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/bcr2246</ArticleId><ArticleId IdType="pmc">PMC2688950</ArticleId><ArticleId IdType="pubmed">19393083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G, Lin Y, Du L, Guan J, Sun S, Sui H, Kou Z, Chan CC, Guo Y, Jiang S, et al. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol. 2010;7:9. doi: 10.1186/1743-422X-7-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-9</ArticleId><ArticleId IdType="pmc">PMC2823673</ArticleId><ArticleId IdType="pubmed">20082709</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Pang X, Deng Y, Liu L, Liang Y, Liu X, Xie L, Wang G, Wang X. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in rat plasma. Int. J. Mass Spectrom. 2007;268:30&#x2013;37. doi: 10.1016/j.ijms.2007.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijms.2007.08.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuang-lai Z, Sheng-shan D, Xin-ru L, Run-hui L, Wei-dong Z, Hong-lin H, Yi Z, Yao-hua H, Shu-ping W. Qualitative and Quantitative Analysis of Alkaloids in Cortex Phellodendri by HPLC-ESI-MS_MS and HPLC-DAD. Chem. Res. Chinese Universities. 2011;27:38&#x2013;44.</Citation></Reference><Reference><Citation>Yan R, Wang Y, Liu Y, Di X. Comparative Pharmacokinetics of Berberine, Palmatine and Jatrorrhizine in Rat Plasma after Oral Administration of Rhizoma coptidis and Zuojinwan Using Liquid Chromatography-Tandem Mass Spectrometry. Iranian J. Pharm. Res. 2012;11:949&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3813130</ArticleId><ArticleId IdType="pubmed">24250523</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CY, Tsai YT, Lai JN, Hsu FL. Prescription pattern of chinese herbal products for diabetes mellitus in taiwan: a population-based study. Evid.-Based Compl. Alt. Med. 2013;2013:201329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3703417</ArticleId><ArticleId IdType="pubmed">23843864</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immuno. Rev. 2007;220:214&#x2013;224. doi: 10.1111/j.1600-065X.2007.00562.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2007.00562.x</ArticleId><ArticleId IdType="pubmed">17979849</ArticleId></ArticleIdList></Reference><Reference><Citation>Boasso A, Type I. Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1. Scientifica. 2013;2013:580968. doi: 10.1155/2013/580968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/580968</ArticleId><ArticleId IdType="pmc">PMC3885208</ArticleId><ArticleId IdType="pubmed">24455433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000;13(4):539&#x2013;548. doi: 10.1016/S1074-7613(00)00053-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(00)00053-4</ArticleId><ArticleId IdType="pubmed">11070172</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Wen Z, Xu LZ, Darnell JE., Jr Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol. Cell. Biol. 1997;17(11):6618&#x2013;6623. doi: 10.1128/MCB.17.11.6618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.17.11.6618</ArticleId><ArticleId IdType="pmc">PMC232515</ArticleId><ArticleId IdType="pubmed">9343425</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh KC, Haque SJ, Williams BR. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO. 1999;18(20):5601&#x2013;5608. doi: 10.1093/emboj/18.20.5601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.20.5601</ArticleId><ArticleId IdType="pmc">PMC1171628</ArticleId><ArticleId IdType="pubmed">10523304</ArticleId></ArticleIdList></Reference><Reference><Citation>David M, Petricoin E, 3rd, Benjamin C, Pine R, Weber MJ, Larner AC. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science. 1995;269(5231):1721&#x2013;1723. doi: 10.1126/science.7569900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7569900</ArticleId><ArticleId IdType="pubmed">7569900</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomerantz JL, Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO. 1999;18(23):6694&#x2013;6704. doi: 10.1093/emboj/18.23.6694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.23.6694</ArticleId><ArticleId IdType="pmc">PMC1171732</ArticleId><ArticleId IdType="pubmed">10581243</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. cell. 1998;1(5):661&#x2013;671. doi: 10.1016/S1097-2765(00)80066-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)80066-0</ArticleId><ArticleId IdType="pubmed">9660950</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham KL, Lee LY, Higgins JP, Steinman L, Utz PJ, Ho PP. Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice. Autoimmunity. 2010;43:140&#x2013;155. doi: 10.3109/08916930903229239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916930903229239</ArticleId><ArticleId IdType="pmc">PMC4150612</ArticleId><ArticleId IdType="pubmed">19845477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolli D, Velayutham TS, Casola A. Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections. Pathog. 2013;2(2):232&#x2013;63. doi: 10.3390/pathogens2020232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens2020232</ArticleId><ArticleId IdType="pmc">PMC3826451</ArticleId><ArticleId IdType="pubmed">24244872</ArticleId></ArticleIdList></Reference><Reference><Citation>Magalhaes PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TC, Pessoa A., Jr Methods of endotoxin removal from biological preparations: A review. J. Pharm. Sci. 2007;10:388&#x2013;40426.</Citation><ArticleIdList><ArticleId IdType="pubmed">17727802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-cancer drugs. 2009;20:757&#x2013;769. doi: 10.1097/CAD.0b013e328330d95b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CAD.0b013e328330d95b</ArticleId><ArticleId IdType="pubmed">19704371</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasa K, Kamigauchi M, Ueki M, Taniguchi M. Antibacterial activity and structure-activity relationships of berberine analogs. Euro. J. Med. Chem. 1996;31:469&#x2013;478. doi: 10.1016/0223-5234(96)85167-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0223-5234(96)85167-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwazaki RS, Endo EH, Ueda-Nakamura T, Nakamura CV, Garcia LB, Filho BP. In vitro antifungal activity of the berberine and its synergism with fluconazole. Anton. Leeuw. 2010;97:201&#x2013;205. doi: 10.1007/s10482-009-9394-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10482-009-9394-8</ArticleId><ArticleId IdType="pubmed">19882381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi K, Minoda K, Nagaoka Y, Hayashi T, Uesato S. Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorganic &amp; medicinal chemistry letters. 2007;17:1562&#x2013;1564. doi: 10.1016/j.bmcl.2006.12.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2006.12.085</ArticleId><ArticleId IdType="pubmed">17239594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Li JQ, Kim YJ, Wu J, Wang Q, Hao Y. In vivo and in vitro antiviral effects of berberine on influenza virus. Chin. J. Integr. Med. 2011;17(6):444&#x2013;452. doi: 10.1007/s11655-011-0640-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-011-0640-3</ArticleId><ArticleId IdType="pubmed">21660679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JB, Zheng JR, Lin Z, Li XY, Cui PG: Research of antiviral mechanisms of action of berberine derivate HB-13 against herpes simplex virus type 2. Chin. J. Antibiot. 2009; 34:376&#x2013;79.</Citation></Reference><Reference><Citation>Wu JB, Zheng JR, Lin Z, Li XY, Cui PG: In vitro antiviral activity of a berberine derivant HB-13 against herpes simplex virus. Chin. J. Dermatol. 2007; 40:671-73.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>